Q8I2A6 AF NFT

Putative zinc carboxypeptidase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeic4lwtz3twhez3yvby5h6myjqvto2kobcdqbzhb3yko6sutwcn2qy/metadata.json
IPFS of structure file: 
bafybeih6tb4sunxdxlt7mdaptnkoznu5kb4qhhsdaqowm2kdp2at45to6q/AF-Q8I2A6-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xdF2b063d4B94F3f46D117B1af99A846bD4a59284
First NFT owner address (bech32): 
genesis1mu4sv02tjnelgmg30vd0nx5yd022ty5y7akg2m
Current NFT ID #53449 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
53449
Accession (UniProt):
Q8I2A6
Name::
Putative zinc carboxypeptidase
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8I2A6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8I2A6|CBPZ1_PLAF7 Putative zinc carboxypeptidase OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PF3D7_0103400 PE=1 SV=2 MLFKNEDSGNGVYCFTYNNFSDVTISDILNIRNDNKNNDNEDNKQDDEEKNDEDDNKSNLLLEENEENKRQGDKPFEDLSLFSFKNNEQCYDNIKMQQAILNSSYEKNVKNIVKIVYHEDCKLLYENTDIHVELPSIVYGRNRNKNNDVVNKCNQYNDDDYTNKCNQYNDDDYTNKCNQYNDDDYTNKCNQYNDNDYTNKCNQYNDNDYTNKCNQYNDVRKITNLKYFINHNWKNINLINEKLFLKNLKELEEILNYNFLHICKNKCKQYNKKRKNERHFSYHDNFLSHYIIYKKNKFIKHNKNEHINGNHYDAHESTNTYDEEKTREKHNNKNNNMKYCLNKYPYDNVNAPLNLSCPWYEKKIENIYCLNIPGYKYKYKYICPSMSKMNDEKIKELYIPKGHILFNSKFESGNLKYVIKEENDKEVYSLFLNPDIRMNEKKNQWFYFSASYVPNEYYTNELYKMKMCNKDINHIGDNMNVVYNYMNGTGNNINNIVNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGNNINNIVNNLDSTVNYMNSTGNYLNRKNNNHLSYTNWSGQRCMNQYLNDINNDEIDTNLDGNRKYSLDACDKFTVRNVRKLEKPFTVRFKIENMAKPFFLYKYGHSPLSFSECKYKIENIQWERNSYDIKYIKNSSCKHYNIKKNSMEYYNYNTYTLEFSYDFTYAYDTVYFASSYPYTYSYLSEYLCLIRNLLKDHPTINYIEERLCKTSCGFDCPVLCITNYDRMEEYNKEELKESVEKKQNIVEANNTCDEKLVDGMDISSNAIRKEIKKKGYILTSKKLDKNRVVNNLFVDMKNGCTRGCASGCTNGCANGYTNGYTNRYTKGCTKGCTNEYSNDNMCKECLDIKNICYQEEKEKCDIIKYNDDKDYSHNCCYEECYNMKREKKKFVCCLSDKCNSFLNEQIKRRRSIMGWNILRNRIKCCKNKMYTSNDFMKTFDSLLKKVYVCKGENKKNNGTKIIKRFEEKYDNNLLFKRKDEKRSLSASPKKKKKKKKKIIVLTARVHPGETNSSYAIHGFIAFIISNNIYAHILREKFIFIIIPMLNIDGVILGNNRYCYNGFDLNRQWSNPIGYIHPTIYSAKLLMKNISENNKIIFFCDFHSHSRKYNCFIFGNEGSYNYVKNKKMCEVFPEIYSHTLPWFALVDTVYKADNENKGSARLISGKEFSLDCSYTFEISLFGIQIRKDFNIMYDEKKDIFYVQNYFEGYQNGDDNIKGGDNIKGGDNIKGDDNINGDDNIKGGDNIKGDDNIKRDDNFQRDDNFQRDDNFQRGDNFHRGDNFHRDDIYDKMNKHYINNNYYYDKNSYDFLYFDENLLFMTGVSFGICLFKFINFLSYHKSSICRRTCEEKEKEHISTETCGILCAKNNKDDEEKCNESKKQNHDAFKTGNSLEFDKGEEHLLSDTHRMVNTFLCNSMNKSKNKNKNKKGYNYILNKYGFIKLKSSKKHIEEVKRIRKLKKKKYMVKEVYELGRKIKQNKYYHNYPFGLYKVNINDVIRILNKINMDDPNGKYKGPGFNNSVDMKKKIKNKNESKTEKKSKTENKSKSKSKNKSKSKNKSKRKKVIVIL